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Aggregated  -amyloid  peptides  play  key  roles  in the development  of Alzheimer’s  disease,  and  recent
evidence  suggests  that  microbial  particles,  among  others,  can  facilitate  their  polymerization.  Bacterial
enzymes,  however,  have  been  proved  to be  beneﬁcial  in degrading  pathological  ﬁbrillar  structures  in
clinical settings,  such  as  strepto-kinases  in  resolving  blood-clots.  The  purpose  of  this  study  was  to  inves-
tigate  the  ability  of bacterial  substances  to effectively  hydrolyze  -amyloid  peptides.  Degrading  products
of  several  proteinases  from  Bacillus  pumilus  were  evaluated  using  MALDI-TOF  mass-spectrometry,  and
their toxicity  was  assessed  in  vitro  using  cell-culture  assays  and  morphological  studies.  These  enzymes
have  proved  to be non-toxic  and were  demonstrated  to  cleave  through  the functional  domains  of  -
amyloid  peptide.  By yielding  inactive  fragments,  proteinases  of  Bacillus  pumilus  may  be used  as  candidate
anti-amyloid  agents.
© 2014 Elsevier  Inc.  All  rights  reserved.
1. Introduction
Alzheimer’s disease (AD) is a slowly progressive primary neuro-
degenerative disorder. Its histo-pathological hallmark features, the
senile plaques, are extra-cellular deposits of -amyloid-peptide
(AP) and impaired cellular brain structures associated with
inﬂammatory elements such as microglia. Although a number of
hypotheses exist around the patho-mechanism of AD, there is per-
haps no single causative agent. It is also dubious if plaques are
responsible for and actively involved in the degenerative process, or
just innocent by-products formed during the course of the disease
that is triggered by yet unknown other factors. According to the
amyloid-theory, soluble monomeric AP is a physiological peptide
with several vital functions in the brain (Wu et al., 1995; Schulz,
1996; Huber et al., 1997; Kamenetz et al., 2000), and aggregation
is key to its neuro-toxicity (Pike et al., 1993; Dumery et al., 2001),
however it is not clearly established what causes polymerization.
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Converging lines of evidence suggest that bacterial and viral par-
ticles might play a role in cerebral amyloidosis seen in AD, and
bacterial endotoxins, among others, have been demonstrated to
promote AP ﬁbrillo-genesis (Reis et al., 2010; Asti and Gioglio,
2014). Neuro-infections may  also lead to global cerebral inﬂam-
mation similar to that is seen in AD brains. In order to facilitate
trans-migration of mono-nuclear leukocytes from the periphery
into the central nervous system (CNS), inﬂammatory mediators
such as cytokines enhance the permeability of blood-brain bar-
rier (BBB) (de Vries et al., 1996). Similarly, Helicobacter pylori
also releases products that could induce break-down of the BBB
(Kountouras et al., 2014). Other micro-organisms such as Herpes
simplex virus type 1 (HSV1) and Chlamydia pneumoniae are postu-
lated to be risk factors for AD (Itzhaki et al., 2004).
In addition to their role in infection, bacteria are also known
for their therapeutic effects. Microbial proteinases are widely used
as medicinal agents, such as the thrombo-lytic drugs staphylo-
and strepto-kinase. Bacterial proteases have several advantages
over similar products of animal origin: they are secreted into the
medium and can easily undergo puriﬁcation, they have high sta-
bility with low patho-genicity and toxicity, and cultivation of the
micro-organisms is also more cost effective. Their role in AP
metabolism, however, is not yet characterized.
AP is continuously produced in low concentrations, and is
rapidly turned over in the normal brain: reduced catabolism may
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